Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathway.
Discov Oncol. 2023 Jul 1;14(1):118. doi: 10.1007/s12672-023-00737-9.
Discov Oncol. 2023.
PMID: 37392305
Free PMC article.
Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting.
Lin Z, Liu L, Li Z, Xu B.
Lin Z, et al.
Exp Hematol Oncol. 2023 Apr 21;12(1):41. doi: 10.1186/s40164-023-00404-3.
Exp Hematol Oncol. 2023.
PMID: 37085931
Free PMC article.
Item in Clipboard
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China.
Lin Z, Zha J, Yi S, Li Z, Ping L, He X, Fan L, Yu H, Zheng Z, Xu W, Chen F, Xie Y, Chen B, Zhang H, Wang L, Ding K, Li W, Yang H, Zhao W, Qiu L, Li Z, Song Y, Xu B.
Lin Z, et al.
Clin Transl Oncol. 2023 Jun;25(6):1821-1829. doi: 10.1007/s12094-023-03081-0. Epub 2023 Feb 19.
Clin Transl Oncol. 2023.
PMID: 36808598
Item in Clipboard
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study.
Zha J, Chen Q, Ye J, Yu H, Yi S, Zheng Z, Xu W, Li Z, Ping L, He X, Zhang L, Li C, Xie Y, Chen F, Sun X, Su L, Zhang H, Fan L, Lin Z, Yang H, Zhao W, Qiu L, Li Z, Song Y, Xu B.
Zha J, et al.
Biomark Res. 2023 Feb 6;11(1):16. doi: 10.1186/s40364-023-00462-z.
Biomark Res. 2023.
PMID: 36747226
Free PMC article.
Item in Clipboard
Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma.
Feng L, Chen K, Huang W, Jiang Y, Sun X, Zhou Y, Li L, Li Y, Deng X, Xu B.
Feng L, et al.
Cell Death Discov. 2022 Jan 28;8(1):39. doi: 10.1038/s41420-022-00833-9.
Cell Death Discov. 2022.
PMID: 35091546
Free PMC article.
Item in Clipboard
Cite
Cite